N
DGX icon

Natixis’s Quest Diagnostics DGX Stock Holding History

Natixis’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.52M Buy
+28,191
New +$5.48M 0.02% 415
2025
Q4 		– Sell
-4,758
Closed -$907K – 1167
2025
Q3 		$907K Sell
4,758
-4,544
-49% -$806K ﹤0.01% 687
2025
Q2 		$1.67M Sell
9,302
-770
-8% -$134K 0.01% 528
2025
Q1 		$1.7M Buy
10,072
+2,893
+40% +$475K 0.01% 466
2024
Q4 		$1.08M Sell
7,179
-7,989
-53% -$1.24M 0.01% 589
2024
Q3 		$2.35M Buy
15,168
+3,996
+36% +$597K 0.01% 409
2024
Q2 		$1.53M Sell
11,172
-8,711
-44% -$1.19M 0.01% 457
2024
Q1 		$2.65M Sell
19,883
-17,043
-46% -$2.21M 0.01% 403
2023
Q4 		$5.09M Sell
36,926
-8,725
-19% -$1.15M 0.04% 293
2023
Q3 		$5.56M Buy
45,651
+4,527
+11% +$603K 0.04% 277
2023
Q2 		$5.78M Sell
41,124
-271,624
-87% -$37.4M 0.05% 275
2023
Q1 		$44.2M Buy
312,748
+193,719
+163% +$27.7M 0.4% 56
2022
Q4 		$18.6M Buy
119,029
+48,501
+69% +$6.97M 0.1% 174
2022
Q3 		$8.66M Buy
70,528
+4,943
+8% +$651K 0.04% 297
2022
Q2 		$8.72M Sell
65,585
-201,180
-75% -$27.4M 0.03% 326
2022
Q1 		$36.5M Buy
266,765
+10,442
+4% +$1.46M 0.13% 170
2021
Q4 		$44.3M Buy
256,323
+203,819
+388% +$31M 0.15% 124
2021
Q3 		$7.63M Buy
+52,504
New +$7.68M 0.03% 429
2021
Q2 		– Sell
-24,422
Closed -$3.13M – 880
2021
Q1 		$3.13M Sell
24,422
-25,759
-51% -$3.17M 0.01% 609
2020
Q4 		$5.98M Buy
50,181
+16,846
+51% +$2.05M 0.02% 483
2020
Q3 		$3.82M Buy
33,335
+14,291
+75% +$1.69M 0.03% 316
2020
Q2 		$2.17M Buy
+19,044
New +$2.02M 0.02% 412
2019
Q4 		– Sell
-143,041
Closed -$15.3M – 860
2019
Q3 		$15.3M Buy
+143,041
New +$14.7M 0.1% 191
2019
Q2 		– Sell
-18,014
Closed -$1.6M – 790
2019
Q1 		$1.6M Sell
18,014
-175,505
-91% -$15.2M 0.01% 521
2018
Q4 		$16.1M Sell
193,519
-5,902
-3% -$553K 0.13% 163
2018
Q3 		$21.5M Buy
199,421
+48,116
+32% +$5.28M 0.12% 173
2018
Q2 		$16.6M Buy
151,305
+133,040
+728% +$13.9M 0.09% 210
2018
Q1 		$1.82M Sell
18,265
-19,094
-51% -$1.96M 0.01% 523
2017
Q4 		$3.68M Buy
37,359
+14,482
+63% +$1.37M 0.03% 335
2017
Q3 		$2.14M Sell
22,877
-28,945
-56% -$3.07M 0.02% 400
2017
Q2 		$5.76M Buy
51,822
+8,351
+19% +$883K 0.07% 227
2017
Q1 		$4.27M Buy
43,471
+22,433
+107% +$2.14M 0.05% 239
2016
Q4 		$1.93M Buy
21,038
+16,432
+357% +$1.42M 0.02% 358
2016
Q3 		$390K Buy
+4,606
New +$387K ﹤0.01% 455
2015
Q3 		– Sell
-2,915
Closed -$211K – 320
2015
Q2 		$211K Sell
2,915
-455
-14% -$33.6K ﹤0.01% 337
2015
Q1 		$259K Buy
+3,370
New +$241K ﹤0.01% 366
2014
Q4 		– Sell
-90,809
Closed -$5.51M – 398
2014
Q3 		$5.51M Buy
+90,809
New +$5.6M 0.08% 145

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Natixis's DGX Position: Q1 2026 in Review

Natixis opened a new position in Quest Diagnostics (DGX) in Q1 2026: 28,191 shares worth $5.52M. The stake represents 0.02% of the portfolio and ranks #415 among its holdings. This is a return to the name: Natixis previously reported a position in DGX as recently as Q3 2025.

Natixis first reported a position in DGX in Q3 2014 and has held it in 37 quarters since. The position peaked at $44.3M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Natixis held 28,191 shares of Quest Diagnostics worth $5.52M as of Q1 2026.
  • Quest Diagnostics was a new Natixis position in Q1 2026.
  • Quest Diagnostics made up 0.02% of Natixis's portfolio in Q1 2026, its #415 holding.
  • Natixis first reported a position in Quest Diagnostics in Q3 2014 and has held it in 37 quarters since.
  • Natixis's Quest Diagnostics position peaked at $44.3M in Q4 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.